4TS Top to Toe Transcatheter Solutions Conference 2025

Menu

Submission Guidelines

Abstract Submission Deadline: 15 January 2025

Submit Abstract

CALL FOR ABSTRACT

4TS Conference invites you to submit your original scientific research or educational exhibit abstract to be considered. Depending on the number of submitted abstracts and their quality, the abstracts will be selected for Poster presentation.

Any abstract received after the deadline will not be accepted. Upon completion of evaluation, an ‘Accepted’ or ‘Rejected’ message will be sent to authors by email, approximately 14 days after the deadline for submission.

Submissions are open until January 15, 2025 18:00, GMT+4.

LANGUAGE

All Abstracts should be submitted in English Only

STRUCTURE OF THE ABSTRACT
  • Abstract title: limited to 150 characters including spaces.
  • Abstract text: limited to 350 words, including acknowledgements.
  • Abstracts should be structured, and prepared as follows:
    • Background and aims
    • Design & Methods
    • Results
    • Conclusions
  • Abstracts must be submitted only in English. Use Times New Roman or Arial font, size 11 or 12.
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appear the first time.
  • Use generic names of drugs.
  • Underline the presenting author’s name.

Non-compliance with these guidelines will lead to rejection of the abstract. The Scientific Committee reserves the rights to reject any submissions.

SUBMISSION PROCESS
  • Abstracts must be submitted via the conference website only
    NOTE: Abstracts submitted by email, fax or post will NOT be accepted. The Scientific Committee will not accept responsibility for any abstracts that have not been properly submitted according to the instructions.
  • Submissions will be accepted from Researchers, Residents, interns and Current medic
  • Abstracts must contain original scientific data collected by the author(s). All abstracts will be reviewed by the Scientific Committee. The Scientific Committee reserves the right to determine whether a submission is accepted as an oral, video or a poster presentation and its decision is final. The Scientific Committee reserves the right to edit abstracts for grammar and clarity.
  • Submission of an abstract acknowledges the authors’ acceptance for the abstract to be published in the conference proceedings. This should be clearly stated on the abstract. Missing this information will lead to rejection of the abstract.
  • Abstracts must be original and must not have been published in a peer-reviewed journal. This should be clearly stated on the abstract and on the poster itself. Missing this information will lead to rejection of the abstract.
  • Conflicts of Interest / Disclosure: Work submitted for presentation must include, with the abstract and on the poster itself, an acknowledgement of funding sources and any potential conflict of interest. Missing this information will lead to rejection of the abstract.
  • All studies must include, with the abstract and on the poster itself, a statement, when applicable, that they have been approved by institutional research ethics committee.
SUBMISSION CATEGORY

All Abstracts must be allocated to one of the following themes:

  • Heart disease and cardiac prevention
  • Vascular and endovascular medicine
  • Cardiac intervention
  • Stroke
  • Leg Ischemia
  • Dyslipidaemia
  • Diabetes
  • HTN
  • Smoking Cessation
ABSTRACT SELECTION AND PRESENTATION
  • The review panel will evaluate submitted abstracts based on the following criteria: scientific or clinical significance, relevance to the conference, alignment of methods with objectives, validity of conclusions supported by objective results, clarity of statements, description of methodology, ethical considerations, originality, quality of English, and overall presentation.
  • After the review process, authors will receive notification of either acceptance or rejection via email.
  • Accepted authors will receive One Complimentary registration pass that will be assigned and sent 10 days prior to the conference.

Our 2024 Sponsors

Diamond

Bronze

Exhibitors

Support

Knowledge Partner

Abdelkader Almanfi

Interventional Cardiologist, Structural & Endovascular Consultant
Baylor St. Luke’s Medical Center
Houston, Texas USA

Dr. Almanfi is a triple board-certified interventional cardiologist and structural and endovascular consultant at Baylor St. Luke’s Medical Center in Houston, Texas. As the Owner and CEO of Houston CardioVascular Care PLLC, he specializes in managing complex cardiac and vascular conditions using advanced, minimally invasive technologies. He completed his medical degree at Al-Arab Medical University in Libya and trained in a fellowship at Baylor College of Medicine’s Texas Heart Institute. Dr. Almanfi is experienced with trans-catheter therapies, including TAVR, MitraClip, Watchman LAAC, and PFO/ASD closures, as well as minimally invasive treatments for complex aortic diseases like EVAR and TEVAR.

This will close in 0 seconds

Abdul Bahro

Interventional Cardiologist, Director of Cardiovascular Services
Merit Health Hospital
USA

Dr. Bahro is an Interventional Cardiologist based in Jackson, MS, affiliated with King's Daughters Medical Center and multiple Merit Health facilities, including Central, Madison, Rankin, River Oaks, and River Region. He specializes in treating conditions such as Atherosclerosis of the Aorta and Acute Deep Vein Thrombosis (DVT), among other conditions at varying frequencies.

This will close in 0 seconds

Abdul Majeed Alzubaidi

Interventional Cardiologist, Medical Advisor, Ministry of Presidential Affairs
Sheikh Khalifa Medical City
SEHA, UAE

Dr. Zubaidi is a Consultant Interventional Cardiologist at Burjeel Hospital, Abu Dhabi. He earned his MBBS degree and completed a cardiology fellowship at the University of British Columbia, Canada.

With extensive experience, including internships at Ministry of Health-approved hospitals and a residency in Internal Medicine, he has developed expertise in interventional cardiology. Dr. Zubaidi holds Level 3 Accreditation in Cardiac CT Performance and Interpretation, achieved during his fellowship at British Columbia Hospital.

His career reflects a strong commitment to advancing cardiovascular care through both academic contributions and clinical excellence.

This will close in 0 seconds

Abdullah Shehab

Professor of Cardiovascular Medicine, Chief Editor, Emirates Medical Journal
Vice President, Gulf Intervention Society
General Secretary, Emirates Cardiac Society
Vice President, Asia Pacific Cardiology
UAE

Prof. Dr. Abdulla Shehab has 25 years of experience in Internal Medicine, Cardiology, Interventional Cardiology, and medical education. He has numerous professional affiliations, including serving as the Immediate Past President of the Emirates Society of Cardiology. He is currently the General Secretary of the Emirates Cardiac Society and the Vice President of the Gulf Intervention Society. Prof. Dr. Shehab is a Fellow of the Royal College of Physicians (UK), the American College of Physicians, the European Society of Cardiology, the American College of Cardiology, the American Society of Cardiac Intervention, and the American Heart Association.

This will close in 0 seconds

Ahmad Hallak

Cardiology Fellow
Ochsner Health
USA

Dr. Ahmad Hallak is a cardiologist in Metairie, Louisiana, and is affiliated with Ochsner Medical Center.

This will close in 0 seconds

Ahmed Elsokkary

Consultant Interventional Cardiologist, Head of Department
Al Zahra Hospital Dubai
UAE

Dr. Elsokkary is a consultant interventional cardiologist with more than 20 years of experience in the field. He completed his training in cardiology and interventional cardiology at a military medical academy and has extensive training in Cardiac Catheterization Lab & Interventional Cardiology, coronary angiograms, and angioplasty. Over 10,000 coronary interventions have been performed by Dr. Elsokkary, and he is an expert in Echo and transesophageal Echo.

This will close in 0 seconds

Allam Alkowatli

Consultant Interventional Cardiologist
Emirates Hospital Jumeirah
UAE

Dr. Allam Alkowatli, recognized as a leading Interventional Cardiologist at Emirates Hospital Dubai, brings extensive expertise from his American Board certifications and distinguished practice in the USA. He completed advanced Fellowship training at William Beaumont Hospital and the University of Alabama, specializing in coronary and peripheral interventions. With a remarkable record of over 4,500 diagnostic angiographies and 3,200 interventions, Dr. Alkowatli remains at the forefront of interventional cardiology. His contributions to research and publications further highlight his commitment to advancing the field and delivering exceptional patient care.

This will close in 0 seconds

Annie Varughese

President, Advanced Cardiovascular Care Center, Specialist Cardiologist
German Heart Center, Prime Hospital, Houston
USA

Based in Houston, Texas, Dr. Varughese serves as Chief of Cardiovascular Services at North Houston Family Medicine and The Woodlands Specialty Hospital. In Dubai, she is a visiting Consultant Interventional Cardiologist at PRIME Hospital and a Specialist Cardiologist at a highly reputed Heart Centre. Dr. Varughese holds an adjunct professorship at Baylor University, Texas, USA, and has been recognized for her expertise in preventive cardiology, women and heart disease, and the prevention and reversal of vascular disease and diabetes. She is board-certified in cardiovascular disease, interventional cardiology, and nuclear cardiology.

This will close in 0 seconds

Arif Nooryani

Professor of Cardiology, CEO & Consultant Interventional Cardiologist
Sharjah University, Al Qassimi Hospital, Sharjah
UAE

Dr. Arif has been the CEO of Al Qassimi Hospital, Sharjah, UAE, since 2009, Head of the Cardiac Cath Lab since 2004, and Head of the Cardiac Centre since 2012. He is a member of the UAE National Committee working towards reducing cardiovascular mortality under the Emirates National Vision 2021 (since May 2016). Additionally, he serves as an Associate Professor of Cardiology at the University of Sharjah (since September 2018) and is pursuing a PhD in Cardiovascular Medicine at the University of Belgrade, Serbia (since 2018).

This will close in 0 seconds

Bassam Baba

Consultant Interventional Cardiologist
Al Qassimi Hospital, Sharjah
Associate Professor at DIU
UAE

This will close in 0 seconds

Cezar A. Iliescu

Interventional Cardiologist, Department of Cardiology, Division of Internal Medicine
MD Anderson Cancer Center
USA

Cezar A. Iliescu is an interventional cardiologist in the Department of Cardiology, Division of Internal Medicine. His clinical and research interests include vascular biology in cancer patients, endovascular treatments for chronic thrombocytopenia, physiologic assessment of coronary stenosis, and the management of radiation-induced cardiovascular disease.

This will close in 0 seconds

Diaa Hakkim

Director of Intravascular Imaging, Director of Vascular and Intravascular Core Lab
Brigham and Women's Hospital, Harvard Medical School
USA

Dr. Diaa Hakkim is an Interventional Cardiologist and Director of the Vascular and Intravascular Imaging Core Laboratory at Brigham and Women's Hospital/Harvard Medical School. He is also a Professor of Cardiovascular Medicine. He is board certified in Interventional Cardiology, Cardiovascular Imaging, and Cardiac CT.

This will close in 0 seconds

Fayaz Shawl

Clinical Professor of Medicine, Director, Interventional Cardiology
George Washington University, Adventist HealthCare White Oak Medical Center
USA

Dr. Fayaz Shawl is the Director of Interventional Cardiology at Adventist HealthCare White Oak Medical Center in Silver Spring, Maryland, and a Clinical Professor of Medicine at George Washington University School of Medicine, Washington, D.C., USA. A pioneer in interventional cardiology, Dr. Shawl performed the first angioplasty at Walter Reed Army Medical Center in 1981 and has since completed over 20,000 angioplasty procedures, placing him among the world’s leading interventionalists.

This will close in 0 seconds

Fekry Eldeeb

Senior Consultant in Interventional Cardiology, Head of Department of Cardiology
NMC Royal Hospital, Sharjah
UAE

Dr. Fekry Fathy Eldeeb is a distinguished senior consultant interventional cardiologist at Fakeeh University Hospital, with over 30 years of expertise in cardiology. Throughout his career, Dr. Eldeeb has held key leadership roles and contributed his expertise across multiple countries, including the UAE, Saudi Arabia, Egypt, Canada, the USA, and the Netherlands.

This will close in 0 seconds